Presentation TCT 2013 Attacking the Adventitia: Rationale, Feasibility, and Early Signals of Efficacy for Restenosis Presenter: Christopher Owens October 27, 2013 REGISTER for free or LOG IN to view this content Iliac Presentation TCT 2013 Up Next Presentation TCT 2013 SFA Stents Can No Longer Be Justified on an Outcomes or Cost Basis! Presenter: Thomas Zeller October 27, 2013 More slides + Presentation TCT 2013 Is the Noncompliant Patient with Severe Treatment Resistant Hypertension an Appropriate Candidate for this Technology? Presenter: Robert Whitbourn October 27, 2013 Presentation TCT 2013 Subintimal Angioplasty (SIA)or Bypass Surgery(BG) in CLI Patients With TASC II Type C/D Lesions. Mid to long term Clinical outcome. Presenter: Sherif Sultan January 31, 2013 We Recommend
Presentation TCT 2013 SFA Stents Can No Longer Be Justified on an Outcomes or Cost Basis! Presenter: Thomas Zeller October 27, 2013
Presentation TCT 2013 Is the Noncompliant Patient with Severe Treatment Resistant Hypertension an Appropriate Candidate for this Technology? Presenter: Robert Whitbourn October 27, 2013
Presentation TCT 2013 Subintimal Angioplasty (SIA)or Bypass Surgery(BG) in CLI Patients With TASC II Type C/D Lesions. Mid to long term Clinical outcome. Presenter: Sherif Sultan January 31, 2013